Acadia Pharmaceuticals | ACAD - Stock





Stock Veränderung Datum
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Cara Therapeutics USD 900K 0 2025-03
Corcept Therapeutics USD 12.87M 519K 2025-12
Cytokinetics USD 0 0 2023-12
Eisai JPY 236.46B 9.14B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Incyte USD 101.06M 17.61M 2025-12
J&J USD 14.19B 45M 2025-12
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12